Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9787110rdf:typepubmed:Citationlld:pubmed
pubmed-article:9787110lifeskim:mentionsumls-concept:C2349001lld:lifeskim
pubmed-article:9787110lifeskim:mentionsumls-concept:C0035647lld:lifeskim
pubmed-article:9787110lifeskim:mentionsumls-concept:C0681850lld:lifeskim
pubmed-article:9787110lifeskim:mentionsumls-concept:C1706203lld:lifeskim
pubmed-article:9787110lifeskim:mentionsumls-concept:C2697811lld:lifeskim
pubmed-article:9787110lifeskim:mentionsumls-concept:C0021641lld:lifeskim
pubmed-article:9787110lifeskim:mentionsumls-concept:C0035696lld:lifeskim
pubmed-article:9787110lifeskim:mentionsumls-concept:C0205217lld:lifeskim
pubmed-article:9787110lifeskim:mentionsumls-concept:C0043655lld:lifeskim
pubmed-article:9787110lifeskim:mentionsumls-concept:C1550501lld:lifeskim
pubmed-article:9787110lifeskim:mentionsumls-concept:C2612546lld:lifeskim
pubmed-article:9787110lifeskim:mentionsumls-concept:C1880177lld:lifeskim
pubmed-article:9787110lifeskim:mentionsumls-concept:C0441712lld:lifeskim
pubmed-article:9787110pubmed:issue2lld:pubmed
pubmed-article:9787110pubmed:dateCreated1998-12-30lld:pubmed
pubmed-article:9787110pubmed:abstractTextOxidative metabolism of glucose is regulated by pyruvate dehydrogenase (PDH) that can be inhibited by isoforms of PDH kinase (PDK). Recently, increased PDK activity has been implicated in the pathogenesis of insulin resistance and non-insulin-dependent diabetes mellitus (NIDDM) in obese subjects. Using quantitative RT-PCR, we measured mRNA of PDK2 and PDK4 isoforms in skeletal muscle biopsies from nondiabetic Pima Indians, a population with a high prevalence of NIDDM associated with obesity. PDK2 and PDK4 mRNAs were positively correlated with fasting plasma insulin concentration, 2-h plasma insulin concentration in response to oral glucose, and percentage body fat, whereas both isoforms were negatively correlated with insulin-mediated glucose uptake rates. Measurements of PDK2 and PDK4 mRNA during the hyperinsulinemic-euglycemic clamp and of PDK2 in cell culture indicated that both transcripts decrease in response to insulin. Increased fatty acid (FA) oxidation has been traditionally viewed as the cause for increased PDK activity contributing to insulin resistance in obese subjects. In contrast, our data indicate that insufficient downregulation of PDK mRNA in insulin-resistant individuals could be a cause of increased PDK expression leading to impaired glucose oxidation followed by increased FA oxidation.lld:pubmed
pubmed-article:9787110pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9787110pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9787110pubmed:languageenglld:pubmed
pubmed-article:9787110pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9787110pubmed:citationSubsetIMlld:pubmed
pubmed-article:9787110pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9787110pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9787110pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9787110pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9787110pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9787110pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9787110pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9787110pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9787110pubmed:statusMEDLINElld:pubmed
pubmed-article:9787110pubmed:monthOctlld:pubmed
pubmed-article:9787110pubmed:issn1096-7192lld:pubmed
pubmed-article:9787110pubmed:authorpubmed-author:HarrisR ARAlld:pubmed
pubmed-article:9787110pubmed:authorpubmed-author:MajerMMlld:pubmed
pubmed-article:9787110pubmed:authorpubmed-author:BogardusCClld:pubmed
pubmed-article:9787110pubmed:authorpubmed-author:ProchazkaMMlld:pubmed
pubmed-article:9787110pubmed:authorpubmed-author:PopovK MKMlld:pubmed
pubmed-article:9787110pubmed:copyrightInfoCopyright 1998 Academic Press.lld:pubmed
pubmed-article:9787110pubmed:issnTypePrintlld:pubmed
pubmed-article:9787110pubmed:volume65lld:pubmed
pubmed-article:9787110pubmed:ownerNLMlld:pubmed
pubmed-article:9787110pubmed:authorsCompleteYlld:pubmed
pubmed-article:9787110pubmed:pagination181-6lld:pubmed
pubmed-article:9787110pubmed:dateRevised2011-11-17lld:pubmed
pubmed-article:9787110pubmed:meshHeadingpubmed-meshheading:9787110-...lld:pubmed
pubmed-article:9787110pubmed:meshHeadingpubmed-meshheading:9787110-...lld:pubmed
pubmed-article:9787110pubmed:meshHeadingpubmed-meshheading:9787110-...lld:pubmed
pubmed-article:9787110pubmed:meshHeadingpubmed-meshheading:9787110-...lld:pubmed
pubmed-article:9787110pubmed:meshHeadingpubmed-meshheading:9787110-...lld:pubmed
pubmed-article:9787110pubmed:meshHeadingpubmed-meshheading:9787110-...lld:pubmed
pubmed-article:9787110pubmed:meshHeadingpubmed-meshheading:9787110-...lld:pubmed
pubmed-article:9787110pubmed:meshHeadingpubmed-meshheading:9787110-...lld:pubmed
pubmed-article:9787110pubmed:meshHeadingpubmed-meshheading:9787110-...lld:pubmed
pubmed-article:9787110pubmed:meshHeadingpubmed-meshheading:9787110-...lld:pubmed
pubmed-article:9787110pubmed:meshHeadingpubmed-meshheading:9787110-...lld:pubmed
pubmed-article:9787110pubmed:meshHeadingpubmed-meshheading:9787110-...lld:pubmed
pubmed-article:9787110pubmed:meshHeadingpubmed-meshheading:9787110-...lld:pubmed
pubmed-article:9787110pubmed:meshHeadingpubmed-meshheading:9787110-...lld:pubmed
pubmed-article:9787110pubmed:meshHeadingpubmed-meshheading:9787110-...lld:pubmed
pubmed-article:9787110pubmed:meshHeadingpubmed-meshheading:9787110-...lld:pubmed
pubmed-article:9787110pubmed:meshHeadingpubmed-meshheading:9787110-...lld:pubmed
pubmed-article:9787110pubmed:meshHeadingpubmed-meshheading:9787110-...lld:pubmed
pubmed-article:9787110pubmed:meshHeadingpubmed-meshheading:9787110-...lld:pubmed
pubmed-article:9787110pubmed:meshHeadingpubmed-meshheading:9787110-...lld:pubmed
pubmed-article:9787110pubmed:year1998lld:pubmed
pubmed-article:9787110pubmed:articleTitleInsulin downregulates pyruvate dehydrogenase kinase (PDK) mRNA: potential mechanism contributing to increased lipid oxidation in insulin-resistant subjects.lld:pubmed
pubmed-article:9787110pubmed:affiliationPhoenix Epidemiology and Clinical Research Branch, National Institutes of Health, Phoenix, Arizona, 85016, USA.lld:pubmed
pubmed-article:9787110pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9787110pubmed:publicationTypeIn Vitrolld:pubmed
pubmed-article:9787110pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
entrez-gene:5166entrezgene:pubmedpubmed-article:9787110lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9787110lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9787110lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9787110lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9787110lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9787110lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9787110lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9787110lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9787110lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9787110lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9787110lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9787110lld:pubmed